Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3977-3979

  Ginsburg, Amy Sarah ^a   Sun, Ronggai ^b   Calamita, Heather ^c   Scott, Cherise P ^a   Bishai, William R ^a   Grosset, Jacques H ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Aeras Global TB Vaccine Foundation   (United States)

^c United States Patent and Trademark Office   (United States)

^d Center for Tuberculosis Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; DIET; DISEASE MODEL; DRUG BLOOD LEVEL; FEMALE; MONOTHERAPY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BODY WEIGHT; DIET; DNA GYRASE; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; EATING; FEMALE; FLUOROQUINOLONES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUBERCULOSIS;

EID: 24144496065     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3977-3979.2005     Document Type: Article

References (14)

1. Bozeman, L., W. Burman, B. Metchock, M. Weiner, and F. Gordin. 2002. Fluoroquinolone susceptibility among selected Mycobacterium tuberculosis isolates from the United States and Canada. Am. J. Respir. Crit. Care Med. 165(Suppl.):A18.
2. Ginsburg, A. S., J. H. Grosset, and W. R. Bishai. 2003. Fluoroquinolones. tuberculosis, and resistance. Lancet Infect. Dis. 3:432-442.
3. Ginsburg, A. S., N. Hooper, N. Parrish, K. E. Dooley, S. E. Dorman, J. Booth, M. Diener-West, W. G. Merz, W. R. Bishai, and T. R. Sterling. 2003. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin. Infect. Dis. 37:1448-1452.
4. Ginsburg, A. S., S. C. Woolwine, N. Hooper, W. H. Benjamin, Jr., W. R. Bishai, S. E. Dorman, and T. R. Sterling. 2003. The rapid development of fluoroquinolone resistance in M. tuberculosis. N. Engl. J. Med. 349:1977-1978.
5. Hong Kong Chest Service/British Medical Research Council. 1992. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tuber. Lung Dis. 73:59-67.
6. Iseman, M. D. 1993. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med. 329:784-791.
7. Kocagoz, T., C. J. Hackbarth, I. Unsal, E. Y. Rosenberg, H. Nikaido, and H. F. Chambers. 1996. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40:1768-1774.
8. Miyazaki, E., M. Miyazaki, J. M. Chien, R. E. Chaisson, and W. R. Bishai. 1999. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob. Agents Chemother. 43:85-89.
9. Nuermberger, E., T. Yoshimatsu, S. Tyagi, W. R. Bishai, and J. H. Grosset. 2003. Activity of moxifloxacin at clinically relevant dosages in the mouse model of tuberculosis. Am. J. Respir. Crit. Care Med. 167(Suppl.):A433.
10. Nuermberger, E. L., T. Yoshimatsu, S. Tyagi, R. J. O'Brien, A. N. Vernon, R. E. Chaisson, W. R. Bishai, and J. H. Grosset. 2004. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am. J. Respir. Crit. Care Med. 169:421-426.
11. O'Brien, R. J. 2003. Development of fluoroquinolones as first-line drugs for tuberculosis-at long last! Am. J. Respir. Crit. Care Med. 168:1266-1268.
12. Stass, H., A. Dalhoff, D. Kubitza, and U. Schuhly. 1998. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrob. Agents Chemother. 42:2060-2065.
13. Sullivan, E. A., B. N. Kreiswirth, L. Palumbo, V. Kapur, J. M. Musser, A. Ebrahimzadeh, and T. R. Frieden. 1995. Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lancet 345:1148-1150.
14. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyro genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.